Check out your Company Bowl for anonymous work chats.
Everyone deserves better health.
Data Strategy: The Importance of Looking Forward, not just measuring the past
We are PMEA 2023 Winners! Lucid are delighted to announce that we have won at the Pharmaceutical Market Excellence Awards (PMEA). We have won the Excellence in Healthcare Professional Education and Support Programmes category for… AbbVie's Open Horizons: An Educational Programme to Raise Standards of Care in Immune-mediated Skin Diseases. The judges' commendations: “Open Horizons had very good insight, a well thought through approach and deep insights based on secondary and detailed primary research. It had strong health outcomes and value. The execution was fantastic. The feedback gathering over a period of time to inform evolving strategy and success was excellent.” We are also proud to have been finalists in the category of ‘Excellence in Capability Development’ for ImmuKNOWLEDGEy: Advancing Immunology in MS. This moment of celebration reflects our peoples’ shared commitment to our vision of Transforming Lives; and we want to take a moment to recognise everyone involved.
We are thrilled to announce that our new Manchester Office is open! In partnership with Work.Life, we are proud to offer an amazing office that not only focuses on happiness in the workplace but is also: *Located in the heart of Manchester city *Champions sustainability using only renewable energy *Certified B Corporation *Fully accessible, aligned with our Disability Confident commitments *Offers access to state-of-the-art meeting rooms and breakout spaces that are perfect for ideation sessions, client presentations and collaboration Thank you to Bryony Evans , Kate Porter and the Work.Life Team for your leadership in this exciting move. Stay tuned for more updates as we settle into our new Manchester home, a place where we can continue on our mission of transforming lives. Always.
Lucid Group has acquired the leading consulting firm, Synetic Life Sciences. The combined capabilities of Lucid and Synetic represents a unique value proposition for the industry, providing clients with an end-to-end partnership across the development and commercialisation journey, delivering transformative solutions across clients’ organisational needs and brand opportunities. It is a significant step forward for Lucid in its mission to improve global health outcomes by building an organisation designed for today’s healthcare challenges and capable of disrupting the service provider model.
Lucid Global is joining the UK Government Disability Confident scheme as part of our commitment to recruiting and supporting colleagues with disabilities. Supporting people with disabilities provides us with access to a wider talent pool and enables us to be a force for good in the world by creating fair and equitable access to employment opportunities. Our actions so far as part of membership of the scheme include: *Offering a guaranteed interview to candidates with disabilities who meet the essential criteria for our role *Guidance for line managers on how to support colleagues with a physical or mental health condition *Reviewing and enhancing our reasonable adjustment and occupational health process Our actions will be louder than our words as we look to create meaningful impact in this important area in the months ahead.
Lucid Group is beyond proud that not one but two of its campaigns scooped top prizes at the Pharmaceutical Market Excellence Awards on Wednesday 23rd November. At a glittering ceremony in London, Sanofi’s ‘Fabry Academy Connect: An Online Rare Disease Medical Education Hub’ triumphed in the Excellence in Rare Diseases or Orphan Drugs category, beating stiff competition with an entry described by the judges as ‘a well-conceived, well-executed initiative’ with ‘a strong element of longevity’. Also winning for Sanofi in the Excellence in Engagement through Integrated Channels category was ‘YouNotFlu’, a multi-channel public health campaign the judges described as ‘what the future of healthcare needs to look like in the digital age’ and ‘a huge step forward towards targeted healthcare interventions’. A special mention, too, to our third entry: BMS’s ‘Optimising HCP engagement through live and on-demand digital channels’, runner-up in the Excellence in Engagement through Digital Channels category. It was a tremendous achievement to reach the finals.
Lucid Group is thrilled that three of its campaigns are finalists at this year’s prestigious Pharmaceutical Market Excellence Awards, with the winners to be announced at a ceremony in London on 23 November. Our work has been recognised in the following categories: Excellence in Rare Disease or Orphan Drugs: For ‘Fabry Academy Connect’, an online educational hub to connect healthcare professionals (HCPs) and improve Fabry disease-related health outcomes. Excellence in Engagement through Integrated Channels: For ‘YouNotFlu’, a multichannel public health campaign that has successfully changed beliefs and behaviours towards flu vaccination. Excellence in Engagement through Digital Channels: For ‘Optimising HCP engagement through live and on-demand digital channels’, a programme consolidating best practice in non-valvular atrial fibrillation and venous thromboembolism. To have three of our campaigns reach the finals is a testament to the creativity and innovative thinking that is the Lucid trademark.
In the April edition of PME, Cheryl Harrison Doyle, Global Asset Strategy Director at Lucid Group discusses the need to take a more considered, outcomes-led approach when launching new medicines today. Click on the link to read whole article. If you’re planning a launch and looking for some advice, get in touch! We’re hosting free launch-strategy clinics throughout May and June. Contact Cheryl Harrison Doyle or Clare Reynolds for more details via email or mobile: cheryl.harrisondoyle@wearelucidgroup.com 07818 568882 clare.reynolds@wearelucidgroup.com 07501 989799
In this year's MedComms guide for wannabe medical writers, Kelly Stroud shares her story about her move from publishing to #MedComms and all the opportunities that have come with it.
